Sodium (1S,2R,3R,4R,5R,6R)-3-((((R)-2,3-bis(hexanoyloxy)propoxy)oxidophosphoryl)oxy)-2,4,5,6-tetrahydroxycyclohexyl hydrogen phosphate

Catalog No. :
ACWDKR902
CAS No. :
1582283-67-7
Molecular Formula :
C21H38Na2O16P2
Molecular Weight :
654.45

IUPAC Name:sodium (1S,2R,3R,4R,5R,6R)-3-((((R)-2,3-bis(hexanoyloxy)propoxy)oxidophosphoryl)oxy)-2,4,5,6-tetrahydroxycyclohexyl hydrogen phosphate

Sodium (1S,2R,3R,4R,5R,6R)-3-((((R)-2,3-bis(hexanoyloxy)propoxy)oxidophosphoryl)oxy)-2,4,5,6-tetrahydroxycyclohexyl hydrogen phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium (1S,2R,3R,4R,5R,6R)-3-((((R)-2,3-bis(hexanoyloxy)propoxy)oxidophosphoryl)oxy)-2,4,5,6-tetrahydroxycyclohexyl hydrogen phosphate
IUPAC Namesodium (1S,2R,3R,4R,5R,6R)-3-((((R)-2,3-bis(hexanoyloxy)propoxy)oxidophosphoryl)oxy)-2,4,5,6-tetrahydroxycyclohexyl hydrogen phosphate
Molecular FormulaC21H38Na2O16P2
Molecular Weight654.45
SMILESCCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@H]1[C@H](O)[C@@H](OP(=O)([O-])O)[C@H](O)[C@@H](O)[C@H]1O)OC(=O)CCCCC.[Na+].[Na+]
InChI KeyFNYBBHFJFSJZJX-IVDIADLUSA-L
SynonymPtdIns-(5)-P1 (1,2-dihexanoyl) (sodium salt)
CAS No.1582283-67-7

Synthetic Route by SureRoute

1. ACWDKR902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRFGT640 route compound structure diagram
    ACRFGT64010051-44-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWDKR902 route product structure diagram
    ACWDKR9021582283-67-7
Inquiry

2. ACWDKR902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWDKR902 route product structure diagram
    ACWDKR9021582283-67-7
Inquiry

Comments (0)